Autoimmune antibody in a hemorrhagic patient interacts with thrombin-activated factor XIII in a unique manner.

Abstract:

:Without a prior history of hemorrhagic disease, a 62-year-old man suffered recurrent episodes of bleeding. Solubility of the patient's clot in 5 mol/L urea indicated a problem with fibrin stabilization. The transamidase activity potential of factor XIII, measured by the incorporation of radioactive putrescine into N,N-dimethylcasein as test substrate, was 62% of control, close to the normal range of values. Examination of the patient's clot from recalcified plasma by sodium dodecyl sulfate-polyacrylamide gel electrophoresis showed that essentially none of the alpha chains and only about two thirds of the gamma chains of fibrin became cross-linked under conditions where both were fully cross-linked in the controls. An antibody to factor XIII was isolated which, although recognizing the recombinant rA2 subunits, as well as the virgin A2B2 plasma ensemble, showed a 100-fold greater affinity for the thrombin-activated rA2' and A2'B2 forms of the zymogen, suggesting that the latter would be its main target during coagulation. Furthermore, the patient's IgG has an ability, never seen before, for inducing an enzymatically active configuration in the thrombin-activated zymogen in the absence of Ca2+.

journal_name

Blood

journal_title

Blood

authors

Lorand L,Velasco PT,Murthy SN,Lefebvre P,Green D

subject

Has Abstract

pub_date

1999-02-01 00:00:00

pages

909-17

issue

3

eissn

0006-4971

issn

1528-0020

journal_volume

93

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia.

    abstract::Chromosome maintenance protein 1 (CRM1) is a nuclear export receptor involved in the active transport of tumor suppressors (e.g., p53 and nucleophosmin) whose function is altered in cancer because of increased expression and overactive transport. Blocking CRM1-mediated nuclear export of such proteins is a novel therap...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-04-423160

    authors: Ranganathan P,Yu X,Na C,Santhanam R,Shacham S,Kauffman M,Walker A,Klisovic R,Blum W,Caligiuri M,Croce CM,Marcucci G,Garzon R

    更新日期:2012-08-30 00:00:00

  • Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell responses.

    abstract::Significant comorbidites and lethality complicate GVHD and its treatment. Targeting the cytokine milieu may improve GVHD control; and IL6 is an attractive candidate, given its role in dendritic cell activation and T-cell differentiation. Tocilizumab is a humanized mAb to IL6-receptor-α (IL6R-α), which is Food and Drug...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363390

    authors: Betts BC,St Angelo ET,Kennedy M,Young JW

    更新日期:2011-11-10 00:00:00

  • The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.

    abstract::The CXC-chemokines interleukin-8 (IL-8), neutrophil-activating peptide-2 (NAP-2), and melanoma growth-stimulatory activity (MGSA) are chemoattractants with high selectivity for neutrophils. Although IL-8 has been shown to act as an extremely potent mediator, reports on NAP-2 and MGSA are still contradictory. Here we s...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ludwig A,Petersen F,Zahn S,Götze O,Schröder JM,Flad HD,Brandt E

    更新日期:1997-12-01 00:00:00

  • Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.

    abstract::Intracranial hemorrhage is the third most frequent cause of cerebrovascular disease, but few genetic risk factors have been associated with its development. Recently, it has been reported that some polymorphisms that affect clotting factors increase the risk for thrombosis. However, reports have analyzed the effect of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.10.2979

    authors: Corral J,Iniesta JA,González-Conejero R,Villalón M,Vicente V

    更新日期:2001-05-15 00:00:00

  • Transplant survivorship: a call to arms.

    abstract::In this issue of Blood, Sun and colleagues from the Bone Marrow Transplant Survivors Study report the chronic health outcomes of more than 1000 survivors of stem cell transplantation. Their results demonstrate a significant burden of chronic conditions among survivors. ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2010-08-299420

    authors: Cutler C

    更新日期:2010-10-28 00:00:00

  • Heterotropic splenic autotransplantation in the prevention of Haemophilus influenza meningitis and fatal sepsis in Sprague-Dawley rats.

    abstract::It has been suggested that autotransplantation of splenic tissue following trauma may result in splenic implanta that protect the human host from severe infection with encapsulated bacteria. To test this hypothesis, Sprague-Dawley rats underwent sham operation, splenectomy, or splenectomy followed by autotransplantati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Moxon ER,Schwartz AD

    更新日期:1980-11-01 00:00:00

  • Expression of human inducible nitric oxide synthase gene in T-cell lines infected with human T-cell leukemia virus type-I and primary adult T-cell leukemia cells.

    abstract::We examined the expression of messenger RNA (mRNA) of the human inducible nitric oxide synthase (hiNOS) gene in a panel of human T-cell lines. Reverse transcriptase-polymerase chain reaction showed that human T-cell leukemia virus type-I (HTLV-I)-infected T-cell lines (MT-1, SLB-1, and C5/MJ) expressed mRNA for the hi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mori N,Nunokawa Y,Yamada Y,Ikeda S,Tomonaga M,Yamamoto N

    更新日期:1999-10-15 00:00:00

  • Evaluation of clinical competence in hematology training programs.

    abstract::The American Board of Internal Medicine (ABIM) has called on directors of hematology training programs to establish systems to evaluate, document, and substantiate those components of overall clinical competence considered essential for certification in the subspecialty. Many of these can be assessed only by repeated ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schrier SL,Benson JA Jr

    更新日期:1988-10-01 00:00:00

  • Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile.

    abstract::High levels of coagulation factor VIII (FVIII) have been associated with cardiovascular disease. Low-density lipoprotein receptor (LDLR) has been recently demonstrated to contribute to FVIII clearance from plasma. The aim of this study was to evaluate 3 single nucleotide polymorphisms in SMARCA4-LDLR gene locus (rs112...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-277079

    authors: Martinelli N,Girelli D,Lunghi B,Pinotti M,Marchetti G,Malerba G,Pignatti PF,Corrocher R,Olivieri O,Bernardi F

    更新日期:2010-12-16 00:00:00

  • Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice.

    abstract::Epidemiologic studies have correlated elevated plasma fibrinogen (hyperfibrinogenemia) with risk of cardiovascular disease and arterial and venous thrombosis. However, it is unknown whether hyperfibrinogenemia is merely a biomarker of the proinflammatory disease state or is a causative mechanism in the etiology. We ra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-316885

    authors: Machlus KR,Cardenas JC,Church FC,Wolberg AS

    更新日期:2011-05-05 00:00:00

  • Molecular cloning of a cDNA encoding canine factor IX.

    abstract::Factor IX (F.IX) is a vitamin K-dependent plasma protein, a deficiency of which results in hemophilia B. A canine model of hemophilia B exists; attempts to use this model for gene transfer experiments or characterization of the hemophilic defect require elucidation of normal canine F.IX structure. We report the isolat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Evans JP,Watzke HH,Ware JL,Stafford DW,High KA

    更新日期:1989-07-01 00:00:00

  • Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.

    abstract::The complex of the serine protease factor IX (FIX) and its cofactor, factor VIII (FVIII), is crucial for propagation of the intrinsic coagulation cascade. Absence of either factor leads to hemophilia, a disabling disorder marked by excessive hemorrhage after minor trauma. FVIII is the more commonly affected protein, e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-05-353672

    authors: Milanov P,Ivanciu L,Abriss D,Quade-Lyssy P,Miesbach W,Alesci S,Tonn T,Grez M,Seifried E,Schüttrumpf J

    更新日期:2012-01-12 00:00:00

  • Recombinant toxins containing human granulocyte-macrophage colony-stimulating factor and either pseudomonas exotoxin or diphtheria toxin kill gastrointestinal cancer and leukemia cells.

    abstract::The granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) is a potential target for toxin-directed therapy, because it is overexpressed on many leukemias and solid tumors and apparently not on stem cells. To investigate the potential therapeutic use of GM-CSF toxins, we fused human GM-CSF to truncated fo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kreitman RJ,Pastan I

    更新日期:1997-07-01 00:00:00

  • Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells.

    abstract::Activation of the mitogen-activated protein (MAP) kinase pathway has been associated with both cell proliferation and differentiation. Constitutively activated forms of Mek (MAP kinase/Erk kinase) and Erk (MAP kinase) have been previously shown capable of inducing differentiation or proliferation in nonhematopoietic c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Melemed AS,Ryder JW,Vik TA

    更新日期:1997-11-01 00:00:00

  • Notes from the Director, National Heart, Lung, and Blood Institute: transitions.

    abstract::During this time of transition in the federal government and the National Institutes of Health, I write to assure the Blood community of the National Heart, Lung, and Blood Institute's (NHLBI) commitment to new and established investigators as outlined in the NHLBI Strategic Plan. This perspective discusses the NHLBI ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-194100

    authors: Nabel EG

    更新日期:2009-03-26 00:00:00

  • Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin.

    abstract::The high iron demand associated with enhanced erythropoiesis during high-altitude hypoxia leads to skeletal muscle iron mobilization and decrease in myoglobin protein levels. To investigate the effect of enhanced erythropoiesis on systemic and muscle iron metabolism under nonhypoxic conditions, 8 healthy volunteers we...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2008-09-178095

    authors: Robach P,Recalcati S,Girelli D,Gelfi C,Aachmann-Andersen NJ,Thomsen JJ,Norgaard AM,Alberghini A,Campostrini N,Castagna A,Viganò A,Santambrogio P,Kempf T,Wollert KC,Moutereau S,Lundby C,Cairo G

    更新日期:2009-06-25 00:00:00

  • Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation.

    abstract::Prothrombin activation can proceed through the intermediates meizothrombin or prethrombin-2. To assess the contributions that these 2 intermediates make to prothrombin activation in tissue factor (Tf)-activated blood, immunoassays were developed that measure the meizothrombin antithrombin (mTAT) and α-thrombin antithr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-05-427856

    authors: Whelihan MF,Zachary V,Orfeo T,Mann KG

    更新日期:2012-11-01 00:00:00

  • Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia.

    abstract::Although the graft-versus-leukemia effect of allogeneic bone marrow transplantation (BMT) is of paramount importance in the maintenance of disease remission, the role played by the autologous T-cell response in antitumor immune surveillance is less defined. We evaluated the emergence of antileukemia cytotoxic T-lympho...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2006-05-021535

    authors: Montagna D,Maccario R,Locatelli F,Montini E,Pagani S,Bonetti F,Daudt L,Turin I,Lisini D,Garavaglia C,Dellabona P,Casorati G

    更新日期:2006-12-01 00:00:00

  • Selective accumulation of virus-specific CD8+ T cells with unique homing phenotype within the human bone marrow.

    abstract::The bone marrow plays a unique role within the immune system. We compared the phenotype and function of virus-specific CD8(+) T cells from matched samples of human peripheral blood and bone marrow. Analysis of virus-specific memory CD8(+) T cells showed widely divergent partition of antigen-specific populations betwee...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-02-138040

    authors: Palendira U,Chinn R,Raza W,Piper K,Pratt G,Machado L,Bell A,Khan N,Hislop AD,Steyn R,Rickinson AB,Buckley CD,Moss P

    更新日期:2008-10-15 00:00:00

  • Platelet-derived VWF is not essential for normal thrombosis and hemostasis but fosters ischemic stroke injury in mice.

    abstract::Von Willebrand factor (VWF) is a key hemostatic protein synthesized in both endothelial cells and megakaryocytes. Megakaryocyte-derived VWF is stored in α-granules of platelets and is enriched in hyperactive "ultra-large" VWF multimers. To elucidate the specific contribution of platelet VWF in hemostasis and thrombosi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-03-632901

    authors: Verhenne S,Denorme F,Libbrecht S,Vandenbulcke A,Pareyn I,Deckmyn H,Lambrecht A,Nieswandt B,Kleinschnitz C,Vanhoorelbeke K,De Meyer SF

    更新日期:2015-10-01 00:00:00

  • Leukemia inhibitory factor upregulates cytokine expression by a murine stromal cell line enabling the maintenance of highly enriched competitive repopulating stem cells.

    abstract::Attempts to maintain or expand primitive hematopoietic stem cells in vitro without the concomitant loss of their differentiative and proliferative potential in vivo have largely been unsuccessful. To investigate this problem, we compared the ability of three cloned bone marrow (BM) stromal cell lines to support the gr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Szilvassy SJ,Weller KP,Lin W,Sharma AK,Ho AS,Tsukamoto A,Hoffman R,Leiby KR,Gearing DP

    更新日期:1996-06-01 00:00:00

  • ALCAM (CD166): its role in hematopoietic and endothelial development.

    abstract::A critical role for the endothelium of yolk sac and dorsal aorta has been shown in embryonic hematopoiesis. A stromal cell line derived from yolk sac, YSCL-72, has been chosen to search for a novel molecule associated with embryonic hematopoiesis. Analysis between YSCL-72 and an adult aorta-derived endothelial cell li...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.7.2134

    authors: Ohneda O,Ohneda K,Arai F,Lee J,Miyamoto T,Fukushima Y,Dowbenko D,Lasky LA,Suda T

    更新日期:2001-10-01 00:00:00

  • Distinct functional properties of highly purified hematopoietic stem cells from mouse strains differing in stem cell numbers.

    abstract::We have previously demonstrated that young adult DBA/2 (DBA) mice have more stem cells than C57BL/6 (B6) mice, as measured in a cobblestone area-forming cell (CAFC) assay using unfractionated marrow. To study the nature of this difference, we have now compared the proliferative fate of single, highly enriched Sca-1(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Haan G,Szilvassy SJ,Meyerrose TE,Dontje B,Grimes B,Van Zant G

    更新日期:2000-08-15 00:00:00

  • Expression and factor-dependent modulation of the interleukin-3 receptor subunits on human hematopoietic cells.

    abstract::Interleukin-3 (IL-3) regulates growth and differentiation of multipotential as well as lineage-committed progenitor cells. The human IL-3 receptor (IL-3R) consists of the alpha and common beta (beta c) subunits. The alpha subunit (IL-3R alpha) is specific for IL-3 and binds IL-3 with low affinity. In contrast, the bet...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sato N,Caux C,Kitamura T,Watanabe Y,Arai K,Banchereau J,Miyajima A

    更新日期:1993-08-01 00:00:00

  • Thrombopoietin signal transduction in purified murine megakaryocytes.

    abstract::Thrombopoietin (TPO) is a recently cloned cytokine that binds to its receptor, Mpl, and promotes hematopoietic expansion and maturation, primarily of the megakaryocyte lineage. The signaling pathways responsible for these events are thought to involve the Janus family of nonreceptor tyrosine kinases (JAKs) and the sig...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Drachman JG,Sabath DF,Fox NE,Kaushansky K

    更新日期:1997-01-15 00:00:00

  • On the target specificity of plasminogen activator inhibitor 1: the role of heparin, vitronectin, and the reactive site.

    abstract::Plasminogen activator inhibitor 1 (PAI-1) is the fast-acting inhibitor of both tissue-type and urokinase-type plasminogen activators (t-PA, u-PA) and is an essential regulatory protein of the fibrinolytic system. In the presence of either the protein vitronectin or the glycosaminoglycan heparin, PAI-1 is also an effic...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Keijer J,Linders M,Wegman JJ,Ehrlich HJ,Mertens K,Pannekoek H

    更新日期:1991-09-01 00:00:00

  • HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes.

    abstract::Bcr-abl fusion peptide-specific CD4+ T-lymphocyte clones have recently been shown to augment colony formation by chronic myelogenous leukemia (CML) cells in a bcr-abl type-specific and HLA class II-restricted manner without addition of exogenous antigen. These findings suggest that CML cells can naturally process and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.5.1498

    authors: Yasukawa M,Ohminami H,Kojima K,Hato T,Hasegawa A,Takahashi T,Hirai H,Fujita S

    更新日期:2001-09-01 00:00:00

  • Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin.

    abstract::Escherichia coli were labeled with 59Fe and then either treated with myeloperoxidase, H2O2, and chloride or opsonized and mixed with human neutrophils. The myeloperoxidase system at pH 7.4 caused release of most of the bacterial 59Fe. A similar result has been obtained by Rosen and Klebanoff (J Biol Chem 257:13731, 19...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Molloy AL,Winterbourn CC

    更新日期:1990-02-15 00:00:00

  • Activation peptides prolong the murine plasma half-life of human factor VII.

    abstract::Coagulation factors VII (FVII), IX (FIX), X (FX), and protein C share the same domain organization but display very different plasma half-lives. It is plausible that the half-life is influenced by the activation peptide, differing in length and glycosylation and missing in FVII. To test this hypothesis, the influence ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-06-290098

    authors: Johansson L,Karpf DM,Hansen L,Pelzer H,Persson E

    更新日期:2011-03-24 00:00:00

  • Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.

    abstract::Rituximab therapy is associated with a long in vivo persistence, yet little is known about the effect of circulating rituximab on B-cell non-Hodgkin lymphoma (B-NHL) targeting by the other available anti-CD20 monoclonal antibodies (MoAbs) (131)iodine-tositumomab and (90)yttrium-ibritumomab tiuxetan. Therefore we asses...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-132142

    authors: Gopal AK,Press OW,Wilbur SM,Maloney DG,Pagel JM

    更新日期:2008-08-01 00:00:00